You are required to be logged in to access the full website
Click here if you have forgotten your username or password
29 July 2026 - US biopharmaceutical company AbbVie (NYSE: ABBV) said on Wednesday it has received European Commission approval for RINVOQ (upadacitinib) to treat adults and adolescents aged 12 and over with severe alopecia areata when taken once dail...
29 July 2026 - Clinical-stage biotechnology company AbCellera Biologics Inc (Nasdaq:ABCL) announced on Wednesday that it has entered into a collaboration with biopharmaceutical company Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) to research, de...
29 July 2026 - Biopharmaceutical company Incyte (Nasdaq:INCY) announced on Wednesday that the European Commission has approved Opzelura (ruxolitinib) cream for adults with moderate atopic dermatitis who have an inadequate response to or cannot use to...
29 July 2026 - Biopharmaceutical company Synlogic Inc (OTC:SYBX) and Caldera Therapeutics Inc, a privately held clinical-stage biotechnology company announced on Wednesday that they have entered into a definitive an all-stock merger agreement to comb...
29 July 2026 - Life sciences investment company RTW Biotech Opportunities Ltd (LSE: RTW) announced on Wednesday that portfolio company Yarrow Bioscience has completed its merger with VYNE Therapeutics Inc and begun trading on the Nasdaq Global Select...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe